Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**Itch Guard** is a topical antifungal cream primarily used to treat skin fungal infections such as ringworm, athlete's foot, jock itch, and infections in skin folds. It contains **Clotrimazole** as the active ingredient in the standard formulation, which inhibits ergosterol synthesis essential for fungal cell membrane integrity, exerting fungistatic and fungicidal effects.[1][5][8] Variants like **Itch Guard Plus** include **Terbinafine Hydrochloride**, which disrupts ergosterol production via squalene epoxidase inhibition for broader antifungal activity, often with added menthol for cooling relief from itching and irritation.[2][3][6] Manufactured by Reckitt Benckiser, it is applied topically once or twice daily to clean, dry affected areas for 1-2 weeks, providing rapid symptom relief including reduced itching, burning, and scaling.[1][3][5]
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Itch Guard.